Urethral filling agent injection connector, injection device

By designing a connector for urethral filler injection and using an endoscope to assist in the extension and retraction of the injection needle, the problems of inconvenient operation and urethral wall damage in the existing technology have been solved, achieving safe and efficient urethral filler injection.

CN224975614UActive Publication Date: 2026-11-17WEST CHINA HOSPITAL SICHUAN UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202521939381.X
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-09-09
Publication Date
2026-11-17
Estimated Expiration
2035-09-09

AI Technical Summary

Technical Problem

In the existing technology, injecting urethral fillers with ordinary syringes is inconvenient and can easily damage the urethral wall.

Method used

Design a urethral filler injection connector, comprising a connecting body, a sliding handle and an endoscope, using the endoscope to assist in the extension and retraction of the injection needle, avoiding direct contact between the needle tip and the urethral wall, and using the endoscope to assist in the injection of urethral filler.

Benefits of technology

This allows for easier injection of fillers into the urethral wall, reducing damage to the urethral wall and improving the safety and precision of the procedure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224975614U_ABST
    Figure CN224975614U_ABST
Patent Text Reader

Abstract

This application provides a urethral filler injection connector and injection device, relating to the technical field of urethral filling equipment. The urethral filler injection connector includes a connecting body with opposing distal and proximal ends, and internally has a first channel and a second channel that are not interconnected. The proximal end of the connecting body is used to connect an endoscope, and the first channel allows the endoscope's barrel to pass through. A sliding handle is connected to one side of the connecting body, slidably connected to the connecting body and movable along the length of the connecting body. The sliding handle has an installation channel communicating with the second channel. The installation channel is used to install an injection cartridge, and the second channel allows an injection needle to pass through, with the injection needle connected to the injection cartridge. When the sliding handle slides along the length of the connecting body, the injection needle can be pushed out of the distal end of the second channel to expose its tip. This allows for convenient injection of filler into the urethral wall and reduces damage to the urethral wall.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application relates to the field of urethral filling equipment technology, and more specifically, to a urethral filling agent injection connector and injection device. Background Technology

[0002] Stress urinary incontinence refers to the involuntary leakage of urine from the urethra when abdominal pressure increases, such as during sneezing, coughing, laughing, exercise, or physical activity. This is due to weakness in the muscles supporting the urethra, pelvic floor muscles, or urethral sphincter. When intra-abdominal pressure suddenly increases, these muscles are unable to control urine flow, resulting in leakage. Common treatments for stress urinary incontinence include physical therapy and surgery. Physical therapy is mainly for milder cases and often uses methods such as electrical stimulation, while surgery is generally more invasive. Currently, a new treatment option is to inject a filler into the urethra to treat stress urinary incontinence. However, this method usually involves injecting a standard syringe (with a needle), which is inconvenient to perform and can easily damage the urethral wall when inserted into the urethra. Utility Model Content

[0003] This application provides a urethral filler injection connector and injection device, which can conveniently inject filler into the urethral wall and reduce damage to the urethral wall.

[0004] This application is implemented as follows: In a first aspect, this application provides a urethral filling injection connector, comprising a connecting body having a distal end and a proximal end opposite to each other along its length, and having a first channel and a second channel that are not interconnected internally, the first channel penetrating the distal end and the proximal end, the second channel penetrating the distal end, the proximal end of the connecting body being used to connect an endoscope, the first channel being used for the passage of the endoscope's barrel; a sliding handle is connected to one side of the connecting body, the sliding handle being slidably connected to the connecting body and capable of moving along the length direction of the connecting body; The sliding handle is provided with an installation channel, which is connected to the second channel; the installation channel is used to install the syringe, and the second channel is used for the injection needle to pass through, with the injection needle connected to the syringe; when the sliding handle slides along the length of the connecting body, the injection needle can be pushed out of the distal end of the second channel to expose the needle tip.

[0005] In one possible implementation, the outer wall of the connecting body is provided with a sliding channel, the sliding channel is arranged along the length direction of the connecting body, the sliding handle has a sliding rod, the sliding rod is disposed in the sliding channel and can slide along the length direction of the sliding channel.

[0006] In one possible implementation, the sliding rod is fitted with a spring, the spring is disposed in the sliding channel, and the end of the spring can abut against the end of the sliding channel near the distal end. The inner wall of the sliding channel is also provided with a limiting groove, and the sliding handle is connected to a limiting member. When the sliding handle slides toward the distal end, the spring can be compressed, the limiting member moves toward the distal end and its end can be embedded in the limiting groove and fixed, so that the sliding handle can stop moving.

[0007] In one possible implementation, the limiting member includes a connecting seat, an elastic telescopic member, and a limiting block. The connecting seat is connected to the sliding handle, and both ends of the elastic telescopic member are connected to the connecting seat and the limiting block, respectively. When the sliding handle slides to the distal end, the elastic telescopic member is compressed, and the limiting block abuts against the inner wall of the sliding channel and slides along the sliding channel. The limiting block can be embedded into the limiting groove under the action of the elastic telescopic member.

[0008] In one possible implementation, the limiting member further includes a lifting portion connected to the connecting seat, the lifting portion being configured to lift the limiting block away from the limiting groove.

[0009] In one possible implementation, the lifting part includes a wheel rotatably connected to the connecting seat, the wheel having a lifting line wound around it, one end of the lifting line being connected to the limiting block; when the wheel rotates, it can tighten the lifting line and pull the limiting block away from the limiting groove.

[0010] In one possible implementation, the surface of the wheel has anti-slip texture.

[0011] In one possible implementation, a rubber sheet is connected to the inner wall of the second channel near the distal end, the rubber sheet sealing the second channel, and the injection needle is able to move within the second channel and puncture the rubber sheet.

[0012] In one possible implementation, the angle between the central axis of the first channel and the central axis of the mounting channel is an acute angle or a right angle.

[0013] Secondly, this application provides a urethral filling agent injection device, including a syringe, an endoscope, and a urethral filling agent injection connector as described in the first aspect; the endoscope is installed at the proximal end, and the barrel of the endoscope extends into the first channel; the syringe includes the syringe barrel and the injection needle, the injection needle is installed in the second channel, the syringe barrel is installed in the installation channel, and the injection needle is fixed to the syringe barrel.

[0014] This application has at least the following beneficial effects: The urethral filler injection connector of this application, in use, involves inserting a syringe pre-filled with filler into the mounting channel of the sliding handle, fixing the syringe barrel in the mounting channel, and positioning the injection needle within the second channel. An endoscope is then connected and fixed to the proximal end of the mounting body, with the endoscope barrel inserted into the first mounting channel. The distal end of the connector is then inserted into the urethra, allowing visualization of the urethra through the endoscope. Once inserted to the target location, the sliding handle can be pushed along the length of the connector, causing the syringe barrel and injection needle to move together, thereby pushing the distal end of the injection needle in the second channel out and exposing the needle tip, enabling injection at the target location.

[0015] The urethral filler injection connector of this application allows for easier injection into the target location on the urethral wall with the aid of an endoscope. Furthermore, during the insertion of the connector into the urethra, the injection needle can be kept within the second channel without protruding distally, thereby avoiding accidental injury to the urethral wall and reducing damage to it. Attached Figure Description

[0016] To more clearly illustrate the technical solutions of the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of this application and should not be regarded as a limitation of the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.

[0017] Figure 1 This is a schematic diagram of the urethral filling agent injection device in the first state according to an embodiment of this application; Figure 2 for Figure 1 Enlarged view of region A in the middle; Figure 3 This is a schematic diagram of the urethral filling agent injection device in the second state according to an embodiment of this application. Figure 4 for Figure 3 Enlarged view of region B in the middle; Figure 5 This is a structural schematic diagram of the connecting body and the limiting member in an embodiment of this application.

[0018] Icons: 100-Urethra filling injection device; 10-Urethra filling injection connector; 11-Connecting body; 111-Distal end; 112-Proximal end; 113-First channel; 114-Second channel; 115-Sliding channel; 1151-Limiting groove; 116-Rubber sheet; 117-Third channel; 13-Sliding handle; 131-Installation channel; 132-Sliding rod; 133-Spring; 14-Limiting component; 141-Connecting seat; 142-Elastic telescopic component; 143-Limiting block; 144-Lifting part; 1441-Rotator; 1442-Lifting line; 20-Syringe; 21-Injection cylinder; 22-Injection needle; 30-Endoscope; 41-Inlet tube; 42-Waste tube. Detailed Implementation

[0019] To make the objectives, technical solutions, and advantages of the embodiments of this application clearer, the technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. The components of the embodiments of this application described and shown in the accompanying drawings can generally be arranged and designed in various different configurations.

[0020] Therefore, the following detailed description of the embodiments of this application provided in the accompanying drawings is not intended to limit the scope of the claimed application, but merely to illustrate selected embodiments of the application. All other embodiments obtained by those skilled in the art based on the embodiments of this application without inventive effort are within the scope of protection of this application.

[0021] In the description of this application, it should be noted that the terms "inner," "outer," etc., indicating the orientation or positional relationship are based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship commonly used when the product is in use. They are used only for the convenience of describing this application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation on this application. In addition, the terms "first," "second," "third," etc., are used only to distinguish descriptions and should not be construed as indicating or implying relative importance.

[0022] In the description of this application, it should also be noted that, unless otherwise expressly specified and limited, the terms "set," "install," and "connect" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a direct connection or an indirect connection through an intermediate medium; and they can refer to the internal connection of two components. Those skilled in the art can understand the specific meaning of the above terms in this application based on the specific circumstances. Example

[0023] This embodiment also provides a urethral filling agent injection device 100, please refer to... Figures 1-4 It includes a syringe 20, an endoscope 30, and a urethral filling connector 10.

[0024] The urethral filler injection connector 10 of this embodiment includes a connecting body 11, which has a distal end 111 and a proximal end 112 along its length. The proximal end 112 refers to the end closer to the operator during use, and the distal end 111 refers to the end farther from the operator during use. The connecting body 11 has three non-communicating channels: a first channel 113, a second channel 114, and a third channel 117, all extending along the length of the connecting body 11. The first channel 113 connects the distal end 111 and the proximal end 112, while the second channel 114 and the third channel 117 connect the distal end 111.

[0025] An endoscope 30 is connected to the proximal end 112 of the connecting body 11. A first channel 113 is used for the passage of the endoscope 30's barrel, which extends into the first channel 113. The endoscope 30's barrel can assist in observing the condition inside the urethra within the first channel 113. The connecting body 11 is connected to an inlet tube 41 and a waste tube 42. Both the inlet tube 41 and the waste tube 42 are connected to a third channel 117. Fluid can be introduced into the third channel 117 through the inlet tube 41. The flushing fluid in the third channel 117 enters the urethra to flush it, and the waste fluid after flushing can be discharged through the waste tube 42.

[0026] Additionally, a sliding handle 13 is connected to one side of the connecting body 11. The sliding handle 13 is slidably connected to the connecting body 11 and can move along the length of the connecting body 11. The sliding handle 13 has a mounting channel 131, which communicates with a second channel 114. The mounting channel 131 is used to mount the syringe 21, and the second channel 114 is used for the passage of the injection needle 22. The injection needle 22 is connected to the syringe 21, which is fixed to the mounting channel 131, and the injection needle 22 extends into the second channel 114. Exemplarily, the angle between the central axis of the first channel 113 and the central axis of the mounting channel 131 is an acute angle or a right angle to facilitate the operation of the syringe 20. Before use, the injection needle 22 is inside the second channel 114, and the needle tip does not extend beyond the distal end 111. When the sliding handle 13 slides along the length of the connecting body 11, the injection needle 22 can be pushed out of the distal end 111 of the second channel 114 to expose the needle tip. Optionally, the injection needle 22 is a bent injection needle with a bending angle of 2~30°. Optionally, the injection needle 22 may also include a needle tip and a plastic tube, with the needle tip fixed to the plastic tube, the plastic tube connected to the injection cylinder 21, and the plastic tube having a certain degree of flexibility to better conform to the second channel 114.

[0027] In use, the urethral filler injection connector 10 of this application involves inserting a syringe 20 pre-filled with filler into the mounting channel 131 of the sliding handle 13, fixing the syringe 21 in the mounting channel 131 and the injection needle 22 within the second channel 114. Exemplarily, the inner wall of the mounting channel 131 is provided with multiple circumferentially arranged protrusions (not shown in the figure), which secure the syringe 21 within the mounting channel 131. An endoscope 30 is connected and fixed to the proximal end 112 of the mounting body, with the barrel of the endoscope 30 inserted into the first mounting channel 131. The distal end 111 of the connecting body 11 is extended into the urethra, allowing visualization of the urethra through the endoscope 30. Once inserted to the target location, the sliding handle 13 can be pushed along the length of the connecting body 11, causing the syringe 21 and injection needle 22 to move together, thereby pushing the injection needle 22 out of the distal end 111 within the second channel 114 and exposing its tip, thus enabling injection at the target location.

[0028] For example, a rubber sheet 116 is connected to the inner wall of the second channel 114 near the distal end 111. The rubber sheet 116 seals the second channel 114, allowing the injection needle 22 to move within the second channel 114 and pierce the rubber sheet 116. After assembling the syringe 20 to the urethral filler injection connector 10, the distal end 111 of the connecting body 11 is inserted into the urethra. If, by accident, the syringe plunger of the syringe 20 is pushed forward, causing the filler to be injected, the rubber sheet 116 within the second channel 114 prevents leakage from the distal end 111. When it is necessary to inject the filler into the urethral wall, the sliding handle 13 can be pushed towards the distal end 111, causing the injection needle 22 to pierce the rubber sheet 116, extend out of the second channel 114, expose the needle tip, and pierce the target urethral wall, after which the filler is injected.

[0029] For example, the outer wall of the connecting body 11 is provided with a sliding channel 115, which is arranged along the length direction of the connecting body 11. A sliding rod 132 is provided at the end of the sliding handle 13 near the distal end 111. The sliding rod 132 is located in the sliding channel 115 and can slide along the length direction of the sliding channel 115. By sliding the sliding rod 132 in conjunction with the sliding channel 115, the movement path of the sliding handle 13 is restricted, making the sliding handle 13 more stable when moving along the length direction of the connecting body 11. In addition, the sliding channel 115 can connect the mounting channel 131 and the second channel 114. When the sliding handle 13 slides towards the distal end 111, the injection needle 22 passes through the sliding channel 115 and can slide within the second channel 114.

[0030] In one embodiment, a spring 133 is fitted onto the sliding rod 132. One end of the spring 133 abuts against the sliding handle 13, and the other end of the spring 133 abuts against one end of the sliding channel 115 near the distal end 111. Exemplarily, the bottom wall of the sliding channel 115 forms a step with the second channel 114 (see reference). Figure 5 This design allows both the sliding rod 132 and the spring 133 to be confined within the sliding channel 115. Furthermore, the top of the sliding channel 115 near its distal end 111 is closed, and the end of the sliding rod 132 near its distal end 111 is located in the closed section, making it difficult for the spring 133 and the sliding rod 132 to disengage from the sliding channel 115.

[0031] The inner wall of the sliding channel 115 is also provided with a limiting groove 1151. The sliding handle 13 is connected to a limiting member 14. The limiting member 14 and the sliding rod 132 are offset from each other and do not interfere with each other. When the sliding handle 13 slides to the distal end 111, the spring 133 can be compressed, the limiting member 14 is driven to move to the distal end 111 and its end can be inserted into the limiting groove 1151 and fixed, so that the sliding handle 13 can stop moving.

[0032] When the sliding handle 13 slides towards the distal end 111, the spring 133 is compressed, allowing the sliding handle 13 to be slowly and gradually pushed towards the distal end 111. During the movement of the limiting member 14 towards the distal end 111, when it reaches the position of the limiting groove 1151, the end of the limiting member 14 is embedded in the limiting groove 1151 and fixed, causing the sliding handle 13 to stop moving and be fixed in a preset fixed position, thus facilitating subsequent injection.

[0033] In one embodiment, the limiting member 14 includes a connecting seat 141, an elastic telescopic member 142, and a limiting block 143. The connecting seat 141 is connected to the sliding handle 13, so when the sliding handle 13 moves along the length direction of the connecting body 11, the connecting seat 141 also moves along the length direction of the connecting body 11. The two ends of the elastic telescopic member 142 are respectively connected to the connecting seat 141 and the limiting block 143. When the sliding handle 13 slides to the distal end 111, the elastic telescopic member 142 is compressed (see reference). Figure 2 and Figure 4 The limiting block 143 abuts against the inner wall of the sliding channel 115 and slides along the length of the sliding channel 115. When the limiting block 143 slides to the position of the limiting groove 1151, the limiting block 143 is embedded in the limiting groove 1151 under the action of the elastic telescopic member 142, so that the limiting block 143 is fixed in the limiting groove 1151, and the sliding handle 13 is prevented from continuing to move. For example, the elastic telescopic member 142 is a compression spring.

[0034] For example, the limiting member 14 also includes a lifting part 144, which is connected to the connecting seat 141. The lifting part 144 is configured to lift the limiting block 143 away from the limiting groove 1151. After the injection is completed, if it is necessary to return the injection needle 22 from the outside of the second channel 114 to the inside of the second channel 114, the limiting block 143 can be lifted away from the limiting groove 1151 by operating the lifting part 144, thereby releasing the limiting effect. Under the restoring force of the spring 133, the sliding handle 13 can be pushed back by the spring 133, thereby causing the sliding handle 13, along with the syringe 21 and the injection needle 22, to retract together, so that the injection needle 22 can return to the second channel 114. Then, the connecting body 11 can be operated to remove the urethral filling injection device 100 from the urethra. With the injection needle 22 located in the second channel 114, accidental damage to the urethral wall by the injection needle 22 can be avoided.

[0035] In one embodiment, the lifting part 144 includes a rotating wheel 1441 rotatably connected to the connecting seat 141. The rotating wheel 1441 has a rotating shaft rotatably mounted on the connecting seat 141. A lifting line 1442 is wound around the rotating wheel 1441. By rotating the rotating wheel 1441 relative to the connecting seat 141, the lifting line 1442 can be retracted or unretracted. One end of the lifting line 1442 is connected to a limiting block 143. When the rotating wheel 1441 rotates, it can tighten the lifting line 1442 and pull the limiting block 143 away from the limiting groove 1151. Exemplarily, the circumferential edge of the rotating wheel 1441 has a protrusion, which is arranged circumferentially and can restrict the lifting line 1442 on the rotating wheel 1441. In addition, the surface of the rotating wheel 1441 has an anti-slip texture, which facilitates operation when rotating the rotating wheel 1441.

[0036] When the sliding handle 13 slides to the distal end 111, the elastic telescopic member 142 is compressed, the limiting block 143 abuts against the inner wall of the sliding channel 115 and slides along the sliding channel 115, and the lifting line 1442 remains in a wound state; when the limiting block 143 moves to the position of the limiting groove 1151 and is embedded in the limiting groove 1151, the lifting line 1442 is released. When the sliding handle 13 needs to be retracted, the operating wheel 1441 rotates to cause the lifting line 1442 to be wound up, the limiting block 143 disengages from the limiting groove 1151, thereby releasing the limiting effect, and under the action of the spring 133's restoring force, the sliding handle 13 can be pushed back by the spring 133.

[0037] In summary, the urethral filler injection connector 10 of this application, with the assistance of the endoscope 30, allows for more convenient injection at the target location on the urethral wall. Furthermore, during the insertion of the connecting body 11 into the urethra, the injection needle 22 can be kept within the second channel 114 without protruding its distal end 111, thereby avoiding accidental injury to the urethral wall and reducing damage to the urethral wall. Further, after injection, the limiting block 143 can be pulled away from the limiting groove 1151 by operating the lifting part 144 to release the limiting effect, allowing the injection needle 22 to return to the second channel 114. Then, the connecting body 11 can be operated to remove the urethral filler injection device 100 from the urethra, with the injection needle 22 remaining within the second channel 114, preventing accidental damage to the urethral wall by the injection needle 22.

[0038] The above are merely preferred embodiments of this application and are not intended to limit this application. Various modifications and variations can be made to this application by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this application should be included within the protection scope of this application.

Claims

1. A urethral bulking agent injection connector, characterized by, It includes a connecting body having a distal end and a proximal end along its length, and having a first channel and a second channel that are not interconnected internally. The first channel passes through the distal end and the proximal end, and the second channel passes through the distal end. The proximal end of the connecting body is used to connect to an endoscope, and the first channel is used for the passage of the endoscope's barrel. A sliding handle is connected to one side of the connecting body, and the sliding handle is slidably connected to the connecting body and can move along the length of the connecting body. The sliding handle is provided with an installation channel, which is connected to the second channel; the installation channel is used to install the syringe, and the second channel is used for the injection needle to pass through, with the injection needle connected to the syringe; when the sliding handle slides along the length of the connecting body, the injection needle can be pushed out of the distal end of the second channel to expose the needle tip.

2. The urethral filling agent injection connector according to claim 1, characterized in that, The outer wall of the connecting body is provided with a sliding channel, which is arranged along the length direction of the connecting body. The sliding handle has a sliding rod, which is located in the sliding channel and can slide along the length direction of the sliding channel.

3. The urethral filling injection connector according to claim 2, characterized in that, The sliding rod is fitted with a spring, which is located in the sliding channel. The end of the spring can abut against the end of the sliding channel near the distal end. The inner wall of the sliding channel is also provided with a limiting groove. The sliding handle is connected to a limiting member. When the sliding handle slides toward the distal end, the spring can be compressed, the limiting member moves toward the distal end and its end can be embedded in the limiting groove and fixed, so that the sliding handle can stop moving.

4. The urethral filling agent injection connector according to claim 3, characterized in that, The limiting component includes a connecting seat, an elastic telescopic component, and a limiting block. The connecting seat is connected to the sliding handle. Both ends of the elastic telescopic component are connected to the connecting seat and the limiting block, respectively. When the sliding handle slides to the distal end, the elastic telescopic component is compressed, and the limiting block abuts against the inner wall of the sliding channel and slides along the sliding channel. The limiting block can be embedded into the limiting groove under the action of the elastic telescopic component.

5. The urethral filler injection connector according to claim 4, characterized in that, The limiting member further includes a lifting part, which is connected to the connecting seat and is configured to lift the limiting block away from the limiting groove.

6. The urethral filler injection connector according to claim 5, characterized in that, The lifting part includes a rotating wheel rotatably connected to the connecting seat, and a lifting line is wound around the rotating wheel. One end of the lifting line is connected to the limiting block. When the rotating wheel rotates, it can tighten the lifting line and pull the limiting block away from the limiting groove.

7. The urethral filler injection connector according to claim 6, characterized in that, The surface of the wheel has anti-slip texture.

8. The urethral filling injection connector according to any one of claims 1 to 7, characterized in that, A rubber sheet is connected to the inner wall of the second channel near the distal end. The rubber sheet seals the second channel, and the injection needle can move within the second channel and pierce the rubber sheet.

9. The urethral filling injection connector according to any one of claims 1 to 7, characterized in that, The angle between the central axis of the first channel and the central axis of the mounting channel is an acute angle or a right angle.

10. A urethral filling agent injection device, characterized in that, The device includes a syringe, an endoscope, and a urethral filling agent injection connector as described in any one of claims 1 to 9; the endoscope is mounted on the proximal end, and the barrel of the endoscope extends into the first channel; the syringe includes the syringe barrel and the injection needle, the injection needle is mounted in the second channel, the syringe barrel is mounted in the mounting channel, and the injection needle is fixed to the syringe barrel.